COMSX | GTTIX | COMSX / GTTIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 2 years | 17 years | - |
Gain YTD | 37.856 | 22.825 | 166% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 1000 | 250% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 114M | 66.4M | 172% |
Annual Yield % from dividends | 0.00 | 0.30 | - |
Returns for 1 year | 38.00 | 24.77 | 153% |
Returns for 3 years | N/A | 3.79 | - |
Returns for 5 years | N/A | 20.67 | - |
Returns for 10 years | N/A | 6.36 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VEMRX | 93.97 | 0.64 | +0.69% |
Vanguard Emerging Mkts Stock Idx InsPlus | |||
RYCFX | 41.26 | 0.28 | +0.68% |
Rydex Biotechnology C | |||
MCGCX | 18.45 | 0.11 | +0.60% |
BlackRock Advantage Global Investor C | |||
WWSYX | 20.39 | 0.02 | +0.10% |
Westwood Quality SmallCap Fund Ultra | |||
GQIRX | 47.43 | N/A | N/A |
Goldman Sachs US Tax-Managed Eq Inv |